Good news: treatments have significantly increased five-year survival for CTEPH
- Robyn Kalda
- Jul 18, 2025
- 1 min read
Since the 1980s, treatment options for patients with chronic thromboembolic pulmonary hypertension (CTEPH) have increased. This study looked at whether five-year survival for CTEPH patients also improved.
The researchers looked at 834 CTEPH patients, dividing them into early (1980s and 1990s), middle (2000s), and late (2010-2023) eras.
Early era patients received CTEPH therapy only 35% of the time, and 68% survived for five years.
Middle era patients received therapy 64% of the time. 85% survived for five years.
Late era patients received therapy 97% of the time, and 93% survived for five years.
Clearly, CTEPH therapies and the long-term prognosis of patients with CTEPH have improved substantially in recent decades.
Great to see survival rates improving for CTEPH patients! By the way, if you ever need to make a quick meme or joke image, I found this site that lets you create a bad quality image easily.
I didn't expect to replay so many stages, but Drive Mad has a nice balance between timing and control without feeling unfair.
The jump from 68% to 93% five-year survival for CTEPH patients across the study eras is remarkable. I wonder if tools like an AI music generator could help support mental well-being during such long treatment journeys.